Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
5.51
-0.18 (-3.16%)
Sep 8, 2025, 1:40 PM - Market open
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $260.26 million as of September 8, 2025. Its market cap has decreased by -65.02% in one year.
Market Cap
260.26M
Enterprise Value
143.27M
1-Year Change
-65.02%
Ranking
Category
Stock Price
$5.51
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from $538.37M to $260.26M, a decrease of -51.66%. That is a compound annual growth rate of -13.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 268.76M | -17.26% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | 610.91M | 13.47% |
| Sep 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.84B |
| Johnson & Johnson | 429.72B |
| AbbVie | 375.50B |
| UnitedHealth Group | 285.64B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 231.38B |